INTERNATIONAL BIOTECHNOLOGY TRUST PLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$1,638,000
-40.9%
151,800
+60.1%
0.37%
-40.2%
Q4 2021$2,771,000
+399.3%
94,800
+334.9%
0.62%
+360.4%
Q3 2021$555,000
-27.3%
21,8000.0%0.13%
-33.3%
Q2 2021$763,000
-14.1%
21,8000.0%0.20%
-14.5%
Q1 2021$888,000
-5.9%
21,8000.0%0.24%
-8.9%
Q4 2020$944,000
-21.5%
21,8000.0%0.26%
-33.5%
Q3 2020$1,202,000
+84.4%
21,800
+122.4%
0.39%
+78.8%
Q2 2020$652,000
+30.9%
9,8000.0%0.22%
-4.4%
Q1 2020$498,000
-72.9%
9,800
-57.6%
0.23%
-65.7%
Q4 2019$1,836,000
+104.7%
23,100
+24.9%
0.66%
+59.3%
Q3 2019$897,000
-39.1%
18,500
-33.9%
0.42%
-24.0%
Q2 2019$1,472,000
-0.6%
28,0000.0%0.55%
-0.2%
Q1 2019$1,481,000
+164.0%
28,000
+36.6%
0.55%
+156.8%
Q2 2017$561,000
-73.7%
20,500
-64.7%
0.21%
-73.9%
Q1 2017$2,134,00058,0000.82%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders